Evidence map›Paper›PMID 27022143›Full record

ArticleThe Journal of experimental medicine2016

NFκB1 is essential to prevent the development of multiorgan autoimmunity by limiting IL-6 production in follicular B cells.

Elisha de Valle, George Grigoriadis, Lorraine A O'Reilly, Simon N Willis, Mhairi J Maxwell, Lynn M Corcoran, Evelyn Tsantikos, Jasper K S Cornish, Kirsten A Fairfax, Ajithkumar Vasanthakumar and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Mice lacking NF-ĸB1 undergo premature ovarian aging.Reproductive biology and endocrinology : RB&E · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. IL-6: a cytokine at the crossroads of autoimmunity.Current opinion in immunology · 2018
    Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. NF-κB p50 (Blood · 2017
    Article
  20. Altered B cell signalling in autoimmunity.Nature reviews. Immunology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 1 country.

Elisha de ValleBurnet Institute, Melbourne, VIC 3004, Australia Immunology, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia.
George GrigoriadisSchool of Clinical Sciences, Monash University, Melbourne, VIC 3004, Australia Center for Cancer Research, Hudson Institute of Medical Research, Melbourne, VIC 3168, Australia Clinical Haematology, Monash and Alfred Health, Melbourne, VIC 3168, Australia.
Lorraine A O'ReillyWalter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia Department of Medical Biology, University of Melbourne, Melbourne, VIC 3050, Australia.
Simon N WillisWalter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia Department of Medical Biology, University of Melbourne, Melbourne, VIC 3050, Australia.
Mhairi J MaxwellImmunology, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia.
Lynn M CorcoranWalter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia Department of Medical Biology, University of Melbourne, Melbourne, VIC 3050, Australia.
Evelyn TsantikosImmunology, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia.
Jasper K S CornishBurnet Institute, Melbourne, VIC 3004, Australia Immunology, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia.
Kirsten A FairfaxWalter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia Department of Medical Biology, University of Melbourne, Melbourne, VIC 3050, Australia.
Ajithkumar VasanthakumarWalter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia Department of Medical Biology, University of Melbourne, Melbourne, VIC 3050, Australia.
Mark A FebbraioGarvan Institute of Medical Research, Darlinghurst, Sydney, NSW 2010, Australia.
Margaret L HibbsImmunology, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia.
Marc PellegriniWalter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia Department of Medical Biology, University of Melbourne, Melbourne, VIC 3050, Australia.
Ashish BanerjeeCenter for Cancer Research, Hudson Institute of Medical Research, Melbourne, VIC 3168, Australia.
Philip D HodgkinWalter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia Department of Medical Biology, University of Melbourne, Melbourne, VIC 3050, Australia.
Axel KalliesWalter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia Department of Medical Biology, University of Melbourne, Melbourne, VIC 3050, Australia.
Fabienne MackayImmunology, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia.
Andreas StrasserWalter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia Department of Medical Biology, University of Melbourne, Melbourne, VIC 3050, Australia.
Steve GerondakisInfection and Immunity Program, Monash Biomedical Discovery Institute, Monash University, Melbourne, VIC 3004, Australia Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC 3004, Australia.
Raffi GugasyanBurnet Institute, Melbourne, VIC 3004, Australia Immunology, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia gugasyan@burnet.edu.au.
Monash University · AUUniversity of Melbourne · AUWalter and Eliza Hall Institute of Medical Research · AUBurnet Institute · AUGarvan Institute of Medical Research · AUHudson Institute of Medical Research · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We examined the role of NFκB1 in the homeostasis and function of peripheral follicular (Fo) B cells. Aging mice lacking NFκB1 (Nfκb1(-/-)) develop lymphoproliferative and multiorgan autoimmune disease attributed in large part to the deregulated activity of Nfκb1(-/-)Fo B cells that produce excessive levels of the proinflammatory cytokine interleukin 6 (IL-6). Despite enhanced germinal center (GC) B cell differentiation, the formation of GC structures was severely disrupted in the Nfκb1(-/-)mice. Bone marrow chimeric mice revealed that the Fo B cell-intrinsic loss of NFκB1 led to the spontaneous generation of GC B cells. This was primarily the result of an increase in IL-6 levels, which promotes the differentiation of Fo helper CD4(+)T cells and acts in an autocrine manner to reduce antigen receptor and toll-like receptor activation thresholds in a population of proliferating IgM(+)Nfκb1(-/-)Fo B cells. We demonstrate that p50-NFκB1 represses Il-6 transcription in Fo B cells, with the loss of NFκB1 also resulting in the uncontrolled RELA-driven transcription of Il-6.Collectively, our findings identify a previously unrecognized role for NFκB1 in preventing multiorgan autoimmunity through its negative regulation of Il-6 gene expression in Fo B cells.

Indexed as

AnimalsAutoimmune DiseasesB-LymphocytesGerminal CenterImmunoglobulin MInterleukin-6MiceMice, KnockoutNF-kappa B p50 SubunitT-Lymphocytes, Helper-InducerTranscription, GeneticImmunoglobulin MInterleukin-6NF-kappa B p50 SubunitNfkb1 protein, mouse

Identifiers

PMID27022143
PMCPMC4821646
OpenAlexW2314890833

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.